Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Itolizumab by Equillium for Lupus Nephritis: Likelihood of Approval
Itolizumab is under clinical development by Equillium and currently in Phase I for Lupus Nephritis. According to GlobalData, Phase I...
Itolizumab by Equillium for Systemic Lupus Erythematosus: Likelihood of Approval
Itolizumab is under clinical development by Equillium and currently in Phase I for Systemic Lupus Erythematosus. According to GlobalData, Phase...
Itolizumab by Equillium for Systemic Lupus Erythematosus: Likelihood of Approval
Itolizumab is under clinical development by Equillium and currently in Phase I for Systemic Lupus Erythematosus. According to GlobalData, Phase...